TI
MRTX

Trexquant Investment’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Trexquant Investment’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,329
Closed -$1.21M – 1819
2022
Q3 		$1.21M Buy
17,329
+11,916
+220% +$882K 0.04% 476
2022
Q2 		$363K Sell
5,413
-20,711
-79% -$1.32M 0.02% 1018
2022
Q1 		$2.15M Buy
26,124
+23,435
+872% +$2.4M 0.1% 250
2021
Q4 		$394K Buy
+2,689
New +$417K 0.02% 777
2021
Q3 		– Sell
-4,850
Closed -$783K – 1582
2021
Q2 		$783K Buy
+4,850
New +$779K 0.07% 365
2021
Q1 		– Sell
-9,742
Closed -$2.14M – 1552
2020
Q4 		$2.14M Buy
+9,742
New +$2.11M 0.23% 115
2019
Q4 		– Sell
-8,665
Closed -$675K – 1321
2019
Q3 		$675K Buy
8,665
+5,005
+137% +$470K 0.06% 374
2019
Q2 		$377K Buy
+3,660
New +$285K 0.03% 541
2019
Q1 		– Sell
-6,964
Closed -$295K – 1393
2018
Q4 		$295K Buy
+6,964
New +$278K 0.02% 787
2018
Q2 		– Sell
-26,650
Closed -$818K – 1308
2018
Q1 		$818K Buy
+26,650
New +$740K 0.06% 473
2017
Q2 		– Sell
-42,879
Closed -$223K – 1261
2017
Q1 		$223K Buy
42,879
+16,447
+62% +$90.1K 0.03% 912
2016
Q4 		$126K Buy
26,432
+4,599
+21% +$25K 0.02% 894
2016
Q3 		$144K Sell
21,833
-26,345
-55% -$140K 0.03% 672
2016
Q2 		$263K Buy
+48,178
New +$768K 0.03% 708
2016
Q1 		– Sell
-29,900
Closed -$945K – 1232
2015
Q4 		$945K Sell
29,900
-6,200
-17% -$219K 0.08% 414
2015
Q3 		$1.24M Buy
+36,100
New +$1.09M 0.11% 331

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Trexquant Investment's MRTX Position: Q4 2022 in Review

Trexquant Investment sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q4 2022, closing a stake of 17,329 shares — an estimated $1.21M sold.

Trexquant Investment first reported a position in MRTX in Q3 2015 and held it in 16 quarters. The position peaked at $2.15M in Q1 2022. 233 funds tracked by Wall St. Rank hold MRTX as of Q4 2022.

  • Trexquant Investment reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Trexquant Investment sold 17,329 Mirati Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.21M.
  • Trexquant Investment first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2015 and held it in 16 quarters.
  • Trexquant Investment's Mirati Therapeutics, Inc. Common Stock position peaked at $2.15M in Q1 2022.
  • 233 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Trexquant Investment's 13F filing for Q4 2022, filed 13 Feb 2023.